Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)

Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Blood Unpaywall

Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)

Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)

BloodNov 11, 2010

Loading next page...
 
/lp/unpaywall/treatment-of-progression-of-philadelphia-negative-myeloproliferative-5MdmArK1yl

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0006-4971
DOI
10.1182/blood-2010-03-274811
Publisher site
See Article on Publisher Site

Abstract

Journal

BloodUnpaywall

Published: Nov 11, 2010

There are no references for this article.